ctDNA clearance is a pretty good thing. pretty good thing

New Post Public Reply Private Reply Replies (0) Message Board
seemingly-harmless
785
ctDNA clearance is a pretty good thing. pretty good thing at 350mg dose. at 2 weeks none the less. with pretty good safe drug leronlimab. thanks to MGK i learned this today. i should be paying more attention but MGK does provide us will a wealth of detail that we often miss. the FACT that there is a cluster effect of occupancy, that its not a 1 to 1 ratio of molecule to receptor, but a cascade of one leronlimab molecule to multiple receptors collapsing on themselves.  ( which we can assume is the foundation for a long acting leronlimab to somehow continue the collapsing effect for a single molecule of lernlimab? )

Quote:
This is why the 350mg dose is working better than traditional receptor occupancy mathematics would predict. The standard calculation assumes each leronlimab molecule blocks exactly one CCR5 receptor on the cell surface. The clustering and internalization mechanism means each leronlimab binding event triggers a cascade that removes multiple receptors simultaneously from the CAML and CTC surface. The functional receptor occupancy achieved at 350mg is substantially higher than the dose-to-receptor ratio calculation suggests, because the drug is not merely occupying individual receptors. It is triggering a cellular reorganization that physically removes receptor clusters from the surface entirely.

Source: https://investorshangout.com/post/view?id=6834626

but back to ctDNA clearance. the fact that this acceptable and reliable test for ctDNA clearance is a blood test, and not an intrusive biopsy, means the science can move way faster and safer than ever before. 

is ctDNA clearance a measurement of how well chemo is working? seems so. 

https://oncodaily.com/oncolibrary/ctdna-clear...after-icis  

will the medical establishment accept that ctDNA clearance is a measurement of how well leronlimab is working? they should...................................................................goose/gander

shouldnt leronlimab be approved for this function alone? there a chemo executive choking on a golf course somewhere today. his game is up. and he knows it.

CytoDyn Inc (CYDY) Stock Research Links

CYDY Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Exploring Growth in the Litigation Funding Investment Market

Updated Category News Views 158

Understanding the Growth of the Litigation Funding Investment Market The litigation funding investment market has shown remarkable growth recently, with projections indicating it could reach USD 53.6 billion by 2032. Starting at a valuation of USD 19.0 billion in 2024, the sector is anticipated to grow at a compound annual growth rate (CAGR) of 13.84% during the forecast...

Continue Reading
Jabil's Future Looks Bright After Solid Fiscal Quarter Results

Updated Category News Views 94

Jabil's Promising Future: Key Insights from Fiscal Q1 Report Jabil (NYSE: JBL) is navigating through some industry challenges, but its latest fiscal Q1 report signals positive momentum. While there was a contraction in top-line revenue, the overall performance exceeded expectations on both the top and bottom lines, and guidance projections were raised above market...

Continue Reading
Exciting Partnerships Announced for The One 2025 Event

Updated Category News Views 271

Exciting Partnerships Announced for The One 2025 Event Businesses join forces to inspire purpose, drive impact, and support a nonprofit mission. The One Experience™, Inc. proudly announces its lineup of sponsors and partners for The One 2025, the organization's flagship annual event. These organizations share a strong commitment to enhancing individual empowerment and...

Continue Reading
Gaby Natale to Inspire Leaders at National Business Conference

Updated Category News Views 195

Gaby Natale Headlines National Business Leadership Conference Washington, D.C. is set to welcome the remarkable Gaby Natale, a triple Emmy Award-winning journalist and bestselling author. Known for her dynamic leadership speaking, Natale will take the stage as a featured guest at an acclaimed event celebrating its 20th anniversary. This year’s National Business...

Continue Reading
Cartera Marks Two Decades of Loyalty Excellence and Growth

Updated Category News Views 145

Cartera Celebrates a Milestone in Loyalty Innovation Cartera, a leading loyalty commerce platform, proudly commemorates its 20th anniversary this year. From its humble beginnings as a startup in 2005, this company has evolved into a prominent name in the industry, generating over $14 billion in sales for its partners. Each year, Cartera facilitates the delivery of 3...

Continue Reading